Francesca Ligorio

MD. Medical Oncology Resident, Istituto Nazionale dei Tumori di Milano

[Francesca Ligorio @franligorio]

Very proud to have been part of this terrific work, just published in @CD_AACR.
Short term calorie restriction is safe, feasible and biologically active in #cancer patients. @AACR @IstTumori

https://t.co/2usiVXH9ZW

https://t.co/2XyKNM3yGr

[Archive: Governor Andrew Cuomo @NYGovCuomo]

Masks work.
Climate change is real.
Vaccines are effective.
Trust scientists.

[Gil Morgan, MD @weoncologists]

Just Out📣 @TheLancetOncol 📰

BROCADE3️⃣sees addition of veliparib to a highly active platinum doublet results in improvement in PFS in germline🧬 #BRCA mutation associated advanced #BreastCancer #BCSM

Indicating utility of platinum➕PARP inhibitors‼️

https://t.co/DB6VAoLqLN

[Francesca Ligorio @franligorio]

Fasting-mimicking diet + CT in breast cancer treatment. Happy to share our comment @NatureComms
https://t.co/eH5sDRrizE
@emmazattarin

[António Guterres @antonioguterres]

Africa has been declared free of polio today.

This historic milestone fills me with hope and optimism.

We can achieve so much when we work together as a global community.

[Henrietta Lacks CELLebrate HeLa @CELLebrateHeLa]

Q2: What has been the impact of HeLa cells in your life or work? #MedTwitter #HELA100 @NIH @NIHDirector #HeLaCells #HenriettaLacks

[NatureRevClinOncol @NatRevClinOncol]

In a phase I study of tucatinib + trastuzumab in pts with progressive HER2+ #breastcancer brain metastasis, intracranial responses were observed 12% & 6% treated twice and once daily, respectively, with overall CBRs of 35% and 53% & mPFS of 3.4 and 4.1 mo: https://t.co/ID9H54VhI1

[The Lancet @TheLancet]

NEW—Mortality from #COVID19 in cancer patients appears to be principally driven by age, gender & comorbidities, with no evidence that cytotoxic chemotherapy or other anticancer treatment increase risk of mortality: UK Coronavirus Cancer Monitoring Project https://t.co/wseXJv18mq

[Federico Nichetti @fedenichetti]

Everolimus vs Alpelisib, who wins? In the #COVID19 days, our work on cancer research goes on! @BioMedCentral https://t.co/MoqaeSp7h9

[Federico Nichetti @fedenichetti]

Is there an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events?
Our work out for Christmas! https://t.co/7HkJUSfzIA
@franligorio @emmazattarin @AntonyMarra @RobertoFerrara_ @marinagarassino @MDPIOpenAccess @Cancers_MDPI